BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 8070888)

  • 1. A pharmacokinetic model to describe toxicokinetic interactions between 1,3-butadiene and styrene in rats: predictions for human exposure.
    Filser JG; Johanson G; Kessler W; Kreuzer PE; Stei P; Baur C; Csanády GA
    IARC Sci Publ; 1993; (127):65-78. PubMed ID: 8070888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interaction between 1,3-butadiene and styrene in Sprague-Dawley rats.
    Laib RJ; Tucholski M; Filser JG; Csanády GA
    Arch Toxicol; 1992; 66(5):310-4. PubMed ID: 1610292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interspecies differences in metabolism and kinetics of 1,3-butadiene, isobutene and styrene.
    Bolt HM
    IARC Sci Publ; 1993; (127):37-44. PubMed ID: 8070883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research strategy for assessing target tissue dosimetry of 1,3-butadiene in laboratory animals and humans.
    Bond JA; Csanády GA; Leavens T; Medinsky MA
    IARC Sci Publ; 1993; (127):45-55. PubMed ID: 8070886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic toxicity of 1,3-butadiene and styrene.
    Norppa H; Sorsa M
    IARC Sci Publ; 1993; (127):185-93. PubMed ID: 8070865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic model describing the disposition of butadiene and styrene in mice.
    Leavens TL; Bond JA
    Toxicology; 1996 Oct; 113(1-3):310-3. PubMed ID: 8901915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,3-Butadiene: toxicity and carcinogenicity in laboratory animals and in humans.
    Melnick RL; Huff J
    Rev Environ Contam Toxicol; 1992; 124():111-44. PubMed ID: 1732994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxicity and cytotoxicity in male B6C3F1 mice following exposure to mixtures of 1,3-butadiene and styrene.
    Leavens TL; Farris GM; James RA; Shah R; Wong VA; Marshall MW; Bond JA
    Environ Mol Mutagen; 1997; 29(4):335-45. PubMed ID: 9212784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of vinyl fluoride in vivo and in vitro.
    Cantoreggi S; Keller DA
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):130-9. PubMed ID: 9073601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene.
    Nauhaus SK; Fennell TR; Asgharian B; Bond JA; Sumner SC
    Chem Res Toxicol; 1996 Jun; 9(4):764-73. PubMed ID: 8831821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent kinetics of inhaled styrene in man.
    Löf A; Johanson G
    IARC Sci Publ; 1993; (127):89-99. PubMed ID: 8070890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans.
    Tardif R; Charest-Tardif G; Brodeur J; Krishnan K
    Toxicol Appl Pharmacol; 1997 May; 144(1):120-34. PubMed ID: 9169076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species-specific pharmacokinetics of styrene in rat and mouse.
    Filser JG; Schwegler U; Csanády GA; Greim H; Kreuzer PE; Kessler W
    Arch Toxicol; 1993; 67(8):517-30. PubMed ID: 8285850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures.
    Thornton-Manning JR; Dahl AR; Allen ML; Bechtold WE; Griffith WC; Henderson RF
    Toxicol Sci; 1998 Feb; 41(2):167-73. PubMed ID: 9520352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose responses for the formation of hemoglobin adducts and urinary metabolites in rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-(14)C]-butadiene.
    Booth ED; Kilgour JD; Watson WP
    Chem Biol Interact; 2004 Mar; 147(2):213-32. PubMed ID: 15013822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the metabolic fate of styrene.
    Sumner SJ; Fennell TR
    Crit Rev Toxicol; 1994; 24 Suppl():S11-33. PubMed ID: 7818768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Styrene-7,8-oxide burden in ventilated, perfused lungs of mice and rats exposed to vaporous styrene.
    Hofmann C; Pütz C; Semder B; Faller TH; Csanády GA; Filser JG
    Toxicol Sci; 2006 Mar; 90(1):39-48. PubMed ID: 16322077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically based modeling of the inhalation kinetics of styrene in humans using a bayesian population approach.
    Jonsson F; Johanson G
    Toxicol Appl Pharmacol; 2002 Feb; 179(1):35-49. PubMed ID: 11884235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.